Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lerner, A Martin ^a   Ariza, Maria E ^b   Williams, Marshall ^b   Jason, Leonard ^c   Beqaj, Safedin ^d   Fitzgerald, James T ^e   Lemeshow, Stanley ^b   Glaser, Ronald ^b  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c DEPAUL UNIVERSITY   (United States)

^d Pathology Inc   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; DEOXYRIBONUCLEOTIDE POLYMERASE; DEOXYURIDINE TRIPHOSPHATE NUCLEOIDOHYDROLASE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA DIRECTED DNA POLYMERASE; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; FAMCICLOVIR; FAMCYCLOVIR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; PROBENECID; PROTEIN P18; UNCLASSIFIED DRUG; VALACICLOVIR; VALACICLOVIR PLUS FAMCICLOVIR; VALGANCICLOVIR; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MALE; SEROLOGY; TREATMENT DURATION; VIRUS CAPSID; WESTERN BLOTTING;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; DNA-DIRECTED DNA POLYMERASE; FATIGUE SYNDROME, CHRONIC; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; PYROPHOSPHATASES;

CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; MIRIDAE; MYCOPLASMA PNEUMONIAE;

EID: 84869143268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047891     Document Type: Article

References (43)

1. Lerner AM, Beqaj SH, Gill K, Edington J, Fitzgerald JT, et al. (2010) An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein-Barr virus (HHV-4): new and emerging treatment strategies. Virus Adaptation and Treatment 2: 135-145.
2. Lerner AM, Beqaj SH, Fitzgerald JT, Gill K, Gill C, et al. (2010) Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome. Virus Adaptation and Treatment 2: 47-57.
3. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, et al. (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159: 2129-2137.
4. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, et al. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121: 953-959.
5. Carruthers B, Jain A, DeMeirleir K, Peterson D, Klimas NG, et al. (2003) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Clinical Working Case Definition, Diagnostic and Treatment Protocols. Journal of Chronic Fatigue Syndrome 11: 7-115.
6. Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S, (2008) The economic impact of ME/CFS: individual and societal costs. Dyn Med 7: 6.
7. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, et al. (2006) Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol 37Suppl 1: S33-38.
8. Klemola E, Kaariainen L, (1965) Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J 2: 1099-1102.
9. Lerner AM, Beqaj SH, Fitzgerald JT, (2008) Validation of the energy index point score to serially measure the degree of disability in patients with chronic fatigue syndrome. In Vivo 22: 799-801.
10. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, et al. (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19: 91-103.
11. Padgett DA, Hotchkiss AK, Pyter LM, Nelson RJ, Yang E, et al. (2004) Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice. J Med Virol 74: 442-448.
12. Sommer P, Kremmer E, Bier S, Konig S, Zalud P, et al. (1996) Cloning and expression of the Epstein-Barr virus-encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme. J Gen Virol 77 (Pt 11): 2795-2805.
13. Glaser R, Litsky ML, Padgett DA, Baiocchic RA, Yang EV, et al. (2006) EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 346: 205-218.
14. Ariza ME, Glaser R, Kaumaya PT, Jones C, Williams MV, (2009) The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182: 851-859.
15. Jones JF, Williams M, (1988) Schooley RT, Robinson C, Glaser R (1988) Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med 148: 1957-1960.
16. Lerner AM, Beqaj SH, (2011) A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome. Virus Adaptation and Treatment 3: 19-24.
17. Klimas NG, Koneru AO, (2007) Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep 9: 482-487.
18. Beqaj SH, Lerner AM, Fitzgerald JT, (2008) Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol 61: 623-626.
19. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT, (2004) IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 18: 101-106.
20. Williams MV, Holliday J, Glaser R, (1985) Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells. Virology 142: 326-333.
21. Cheng YC, Chen JY, Hoffmann PJ, Glaser R, (1980) Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. Virology 100: 334-338.
22. Henry BE, Glaser R, Hewetson J, O'Callaghan DJ, (1978) Expression of altered ribonucleotide reductase activity associated with the replication of the Epstein-Barr virus. Virology 89: 262-271.
23. Miller RL, Glaser R, Rapp F, (1977) Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76: 494-502.
24. Glaser R, Ogino T, Zimmerman J Jr, Rapp F, (1973) Thymidine kinase activity in Burkitt lymphoblastoid somatic cell hybrids after induction of the EB virus. Proc Soc Exp Biol Med 142: 1059-1062.
25. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207-211.
26. Cheng YC, Chen JY, Glaser R, Henle W, (1980) Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 77: 6162-6165.
27. Liu MY, Chou WH, Nutter L, Hsu MM, Chen JY, et al. (1989) Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J Med Virol 28: 101-105.
28. de Turenne-Tessier M, Ooka T, Calender A, de The G, Daillie J, (1989) Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase. Int J Cancer 43: 45-48.
29. Henle G, Henle W, Klein G, (1971) Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer 8: 272-282.
30. Henle W, Ho HC, Henle G, Kwan HC, (1973) Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. J Natl Cancer Inst 51: 361-369.
31. Glaser R, Zhang HY, (1987) The importance of viral markers in the study of Epstein-Barr virus-associated illness. Bulletin de L'Institut Pasteur 85: 189-200.
32. Capuron L, Dantzer R, (2003) Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17Suppl 1: S119-124.
33. Watkins LR, Maier SF, (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257: 139-155.
34. Deng JH, Zhang YJ, Wang XP, Gao SJ, (2004) Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation. J Virol 78: 11108-11120.
35. Mathes LE, Olsen RG, Hebebrand LC, Hoover EA, Schaller JP, et al. (1979) Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res 39: 950-955.
36. Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, et al. (2000) Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165: 663-670.
37. D'Addario M, Ahmad A, Morgan A, Menezes J, (2000) Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases. J Mol Biol 298: 765-778.
38. Fluge O, Bruland O, Krista R, Storstein A, Kristoffersen EK, et al. (2011) Benefit from B-Lymphocyte Depletion Using the Anti-CD20 rituximab in Chronic Fatigue Syndrome A Double-Blind and Placebo-Controlled Study. PLoS 6: 1-13.
39. Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, et al. (2012) A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS ONE 7: e31334.
40. Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, et al. (2009) Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206: 2091-2099.
41. Natelson BH, Ye N, Moul DE, Jenkins FJ, Oren DA, et al. (1994) High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 42: 42-46.
42. Levine PH, Pilkington D, Strickland P, Peterson D, (2000) Chronic Fatigue Syndrome and Cancer. Journal of Chronic Fatigue Syndrome 7: 29-38.
43. Chang CM, Warren JL, Engels EA (2012) Chronic Fatigue Syndrome and Subsequent Risk of Cancer Among Elderly US Adults. Cancer. doi: 10.1002/cncr.27612.